Dihydrothymine

Dihydrothymine is a chemical compound that plays a significant role in the metabolism of nucleic acids. It is a reduced form of thymine, one of the four nucleobases used in the synthesis of DNA. Dihydrothymine is involved in the pyrimidine metabolism pathway, which is crucial for the synthesis and degradation of pyrimidine nucleotides.
The conversion of thymine to dihydrothymine is catalyzed by the enzyme dihydropyrimidine dehydrogenase (DPD), which is a key enzyme in the catabolism of thymine and uracil, another pyrimidine nucleobase. This reaction is part of the process by which cells recycle nucleic acid components.
Dihydrothymine accumulation in the body is associated with a rare genetic disorder known as Dihydropyrimidinuria. This condition results from a deficiency in dihydropyrimidine dehydrogenase, leading to elevated levels of dihydrothymine and other pyrimidine metabolites in the urine. Patients with dihydropyrimidinuria may exhibit a range of symptoms, including developmental delays, seizures, and, in some cases, intellectual disability. The severity of symptoms can vary widely among affected individuals.
The detection of elevated dihydrothymine levels in urine is used diagnostically to identify dihydropyrimidinuria. Treatment strategies for this condition are primarily supportive and aimed at managing symptoms, as there is currently no cure for dihydropyrimidinuria.
In addition to its role in human metabolism and disease, dihydrothymine is also of interest in the field of biochemistry for its applications in research, particularly in studies related to DNA synthesis and repair mechanisms.
-
5,6-Dihydrothymin structure
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
